Literature DB >> 20871493

Factors associated with repeat syphilis testing at a large urban LGBT health clinic: Chicago, IL 2002-2008.

Anna L Hotton1, Beau Gratzer, Daniel Pohl, Supriya D Mehta.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends clinical and serologic re-evaluation at 6 and 12 months after diagnosis with early syphilis, to determine treatment efficacy.
METHODS: This was a retrospective cohort study of men who have sex with men enrolled in primary care at a lesbian, gay, bisexual, and transgender health center. We used multivariable Poisson regression to examine associations between patient characteristics and timely follow-up (return clinic visit within 6 months of initial diagnosis) and among patients with timely follow-up, factors associated with rescreening at the follow-up visit.
RESULTS: January 2002 through December 2008, 5788 tests for syphilis were performed; 256 (4.4%) cases of early syphilis were detected among 225 men. Of 225 134 (59.6%) had timely follow-up. After implementation of electronic medical records and enhanced DIS follow-up, timely follow-up increased from 53% to 76% and rescreening increased from 64% to 81%. HIV-positive men were more likely to have timely follow-up (adjusted relative risk [aRR]=1.93; 95% CI: 1.31-2.85), as were patients diagnosed 2007-2008 (aRR=1.28; 95% CI: 1.04-1.57). Among patients with timely follow-up, 94 (70%) were rescreened for syphilis. Diagnosis in 2007-2008 was associated with a greater likelihood that the patient was rescreened at the follow-up visit (aRR=1.24; 95% CI: 1.00-1.53).
CONCLUSIONS: Timely follow-up and rescreening improved during the study period, subsequent to implementation of electronic medical records and enhanced DIS follow-up. Even in this later period, the combination of lack of timely follow-up and rescreening resulted in 39% of patients without CDC recommended follow-up. Further efforts are needed to improve timely follow-up by patients and rescreening by clinicians.

Entities:  

Mesh:

Year:  2011        PMID: 20871493     DOI: 10.1097/OLQ.0b013e3181f41dc0

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

Review 1.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

2.  Syphilis Testing Among Sexually Active Men Who Have Sex With Men and Who Are Receiving Medical Care for Human Immunodeficiency Virus in the United States: Medical Monitoring Project, 2013-2014.

Authors:  Alex de Voux; Kyle T Bernstein; Heather Bradley; Robert D Kirkcaldy; Yunfeng Tie; R Luke Shouse
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

3.  Laboratory Evaluation of the DPP Syphilis Screen & Confirm Assay.

Authors:  Silver K Vargas; Jazmin Qquellon; Francesca Vasquez; Kelika A Konda; Gino Calvo; Michael Reyes-Diaz; Carlos Caceres; Jeffrey D Klausner
Journal:  Microbiol Spectr       Date:  2022-05-31

4.  Epidemiologic characteristics of an ongoing syphilis epidemic among men who have sex with men, San Francisco.

Authors:  Kyle T Bernstein; Sally C Stephens; Frank V Strona; Robert P Kohn; Susan S Philip
Journal:  Sex Transm Dis       Date:  2013-01       Impact factor: 2.830

5.  A randomised controlled trial to evaluate the impact of sexual health clinic based automated text message reminders on testing of HIV and other sexually transmitted infections in men who have sex with men in China: protocol for the T2T Study.

Authors:  Huachun Zou; Xiaojun Meng; Andrew Grulich; Shujie Huang; Tianjian Jia; Xuan Zhang; Zhenzhou Luo; Yi Ding; Ligang Yang; Jinmei Huang; Weiying Chen; Heping Zheng; Bin Yang
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.